🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchTRIUMPH program (retatrutide) — my results so far Page 9

TRIUMPH program (retatrutide) — my results so far

BenResearch_OR Tue, Nov 5, 2024 at 9:18 PM 42 replies 1,987 viewsPage 9 of 9
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Nov 6, 2024 at 10:03 AM#41

Subscribing to this thread. TRIUMPH program is exactly what I've been researching. 🙏

48 1VendorMark, COA_Karl, MikeFit_NJ and 45 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
Nov 6, 2024 at 10:20 AM#42

+1 to mike_mealprep. Especially the point about "Follow-up question: did you change anyth..." — I have seen the same in my own experience with TRIUMPH program.

40 22TomTeleRx, DoseLogDan, SleepFixSam and 37 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Nov 6, 2024 at 10:37 AM#43

Yep. My endo said the same thing about TRIUMPH program.

22 10Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Nov 6, 2024 at 10:54 AM#44

+1 to lisa_labSD. Especially the point about "The first 6 weeks are the hardest..." — I have seen the same in my own experience with TRIUMPH program.

35 0Dr.LeslieOBGYN, MikeNYC_runner and 32 others
Reply Quote Save Share Report
adam_van
Member
212
890
Nov 2024
Vancouver, CA
Nov 6, 2024 at 11:11 AM#45

Following this thread closely. TRIUMPH program is something I'm actively working through.

43 14hyun_seoul, jim_asheville, matt_MKE and 40 others
Reply Quote Save Share Report
1789

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register